Replies to post #332414 on Avid Bioservices Inc (CDMO)

[Threes]

Thank you Jake good to know. Really think we should know more about the details of the milestone payments.

Maybe these guys took a page from Epstien who took Cotara to China got it approved.

We bounced nicely off 5.05 with limited shares to be had we could see some big swings.

[biopharm]

All those trials with Merck and Bavituximab ...nice

Thanks for the reminder Jake and I wonder how Mr Weissman would do in a deposition to go on the record with Peregrine Pharmaceuticals talks with Merck...looks like Merck never really could handle not being able to deal with Steve King and they had other plans to wait for the IP assets and Biomarkers

___


Stephen Weissman

Merck & Co., Inc. in its oncology collaboration with AstraZeneca, and its acquisitions of Peloton Therapeutics and Immune Design Corp.

Merck & Co., Inc. in various acquisitions and potential acquisitions, in the company's defense of competition law claims in various jurisdictions

https://www.bakerbotts.com/people/w/weissman-stephen?tab=experience